[Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)].

A Ahr, A Rody, S Kissler, M Kaufmann, R Gätje
{"title":"[Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)].","authors":"A Ahr,&nbsp;A Rody,&nbsp;S Kissler,&nbsp;M Kaufmann,&nbsp;R Gätje","doi":"10.1055/s-2006-942280","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The incidence of vulvar intraepithelial neoplasia (VIN) has increased in the last decades. The therapy of VIN is the in toto resection. Still some patients develop VIN recurrence. The aim of this retrospective study is the identification of risk factors for VIN recurrence.</p><p><strong>Material and methods: </strong>68 Patients with VIN III has been examined in an univariate and multivariate analysis for the following parameters (follow-up: median 27 months): age, HPV, HIV, multicentricity, resection margins (1-4 mm, 5-9 mm, > or = 10 mm).</p><p><strong>Results: </strong>In the univariate analysis positive HPV and HIV status correlated with VIN recurrence. Also resection margins < 5 mm showed a significant correlation with VIN recurrence. Multivariate analysis demonstrated that HPV, HIV and resection margins < 5 mm are independent risk factors. No statistically association was found for age and multicentricity.</p><p><strong>Conclusion: </strong>The aim of VIN therapy must be the total resection with a negative resection margin of > or = 5 mm. HPV- and/or HIV-positive patients have a significantly higher risk for VIN recurrence and need therefore an intensive follow up.</p>","PeriodicalId":23881,"journal":{"name":"Zentralblatt fur Gynakologie","volume":"128 6","pages":"347-51"},"PeriodicalIF":0.0000,"publicationDate":"2006-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2006-942280","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zentralblatt fur Gynakologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-2006-942280","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Objective: The incidence of vulvar intraepithelial neoplasia (VIN) has increased in the last decades. The therapy of VIN is the in toto resection. Still some patients develop VIN recurrence. The aim of this retrospective study is the identification of risk factors for VIN recurrence.

Material and methods: 68 Patients with VIN III has been examined in an univariate and multivariate analysis for the following parameters (follow-up: median 27 months): age, HPV, HIV, multicentricity, resection margins (1-4 mm, 5-9 mm, > or = 10 mm).

Results: In the univariate analysis positive HPV and HIV status correlated with VIN recurrence. Also resection margins < 5 mm showed a significant correlation with VIN recurrence. Multivariate analysis demonstrated that HPV, HIV and resection margins < 5 mm are independent risk factors. No statistically association was found for age and multicentricity.

Conclusion: The aim of VIN therapy must be the total resection with a negative resection margin of > or = 5 mm. HPV- and/or HIV-positive patients have a significantly higher risk for VIN recurrence and need therefore an intensive follow up.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
外阴上皮内瘤变复发的危险因素III (VIN III)。
目的:近几十年来,外阴上皮内瘤变(VIN)的发病率呈上升趋势。VIN的治疗方法是全切除。仍有部分患者出现VIN复发。本回顾性研究的目的是确定VIN复发的危险因素。材料和方法:68例VIN III患者在单因素和多因素分析中进行了以下参数的检查(随访:中位27个月):年龄,HPV, HIV,多中心性,切除边缘(1-4 mm, 5-9 mm, >或= 10 mm)。结果:在单因素分析中,HPV和HIV阳性与VIN复发相关。切缘< 5mm也与VIN复发有显著相关性。多因素分析表明,HPV、HIV和切缘< 5mm是独立的危险因素。年龄和多中心性之间没有统计学关联。结论:VIN治疗的目的必须是全切,阴性切缘>或= 5mm。HPV和/或hiv阳性患者VIN复发的风险明显更高,因此需要加强随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Units of measurement]. [Not significant--what now?]. [Fluorescence diagnosis and photodynamic therapy with 5-aminolevulinic acid induced protoporphyrin IX in gynecology: an overview]. [Chemotherapy for metastatic breast cancer]. [The expert patient: medical consequences].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1